Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study

Background. The present paper described the biological characteristics and clinical behavior of young women in the cohort NORA study Patients and Methods. From 2000–2002, patients (𝑁>3500) were enrolled at 77 Italian hospitals. Women aged ≤50 years (𝑁=1013) were stratified into age groups (≤35...

Full description

Saved in:
Bibliographic Details
Main Authors: P. Pronzato, G. Mustacchi, A. De Matteis, F. Di Costanzo, E. Rulli, I. Floriani, M. E. Cazzaniga
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.4061/2011/534256
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552650008166400
author P. Pronzato
G. Mustacchi
A. De Matteis
F. Di Costanzo
E. Rulli
I. Floriani
M. E. Cazzaniga
author_facet P. Pronzato
G. Mustacchi
A. De Matteis
F. Di Costanzo
E. Rulli
I. Floriani
M. E. Cazzaniga
author_sort P. Pronzato
collection DOAJ
description Background. The present paper described the biological characteristics and clinical behavior of young women in the cohort NORA study Patients and Methods. From 2000–2002, patients (𝑁>3500) were enrolled at 77 Italian hospitals. Women aged ≤50 years (𝑁=1013) were stratified into age groups (≤35, 36–40, 41–45, and 46–50 years). The relationship between age and patient characteristics, cancer presentation, and treatment was analyzed. Results. Younger women more frequently had tumors with ER/PgR-negative(𝜒2=7.07; 𝑃=.008), HER2 amplification (𝜒2=5.76; 𝑃=.01), and high (≥10%) Ki67 labelling index (𝜒2=9.53; 𝑃=.002). Positive nodal status, large tumors, and elevated Ki67 all associated with the choice for chemotherapy followed by endocrine therapy in hormone receptor-positive patients (𝑃<.0001). At univariate analysis, ER-ve status, chemotherapy and age resulted as the only statistically significant variables (HR=2.02, 𝑃=.004, and >40 versus ≤40, 𝑃<.0001, resp.). At multivariate analysis, after adjustment for significant clinical and pathological factors, age remains a significant prognostic variable (HR=0.93, 𝑃=.0021). Conclusion. This cohort study suggests that age per sè is an important prognostic factor. The restricted role of early diagnosis and the aggressive behavior of cancer in this population make necessary the application of targeted medical strategies crucial.
format Article
id doaj-art-790547fea42149f0b0cb1fc00ff4ab70
institution Kabale University
issn 2090-3189
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Breast Cancer
spelling doaj-art-790547fea42149f0b0cb1fc00ff4ab702025-02-03T05:58:10ZengWileyInternational Journal of Breast Cancer2090-31892011-01-01201110.4061/2011/534256534256Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA StudyP. Pronzato0G. Mustacchi1A. De Matteis2F. Di Costanzo3E. Rulli4I. Floriani5M. E. Cazzaniga6Oncologia Medica, IST, Genova 16010, ItalyMedical Oncology Department, University of Trieste, Trieste 34010, ItalyMedical Oncology C, National Cancer Institute, G. Pascale Foundation, Napoli 80010, ItalyMedical Oncology, Careggi University Hospital, Firenze 50012, ItalyOncology Department, Mario Negri Institute for Pharmacological Research, Milano 20100, ItalyOncology Department, Mario Negri Institute for Pharmacological Research, Milano 20100, ItalyMedical Oncology, San Gerardo Hospital, Az Osp San Gerardo, Via Pergolesi 33, 20052 Monza, ItalyBackground. The present paper described the biological characteristics and clinical behavior of young women in the cohort NORA study Patients and Methods. From 2000–2002, patients (𝑁>3500) were enrolled at 77 Italian hospitals. Women aged ≤50 years (𝑁=1013) were stratified into age groups (≤35, 36–40, 41–45, and 46–50 years). The relationship between age and patient characteristics, cancer presentation, and treatment was analyzed. Results. Younger women more frequently had tumors with ER/PgR-negative(𝜒2=7.07; 𝑃=.008), HER2 amplification (𝜒2=5.76; 𝑃=.01), and high (≥10%) Ki67 labelling index (𝜒2=9.53; 𝑃=.002). Positive nodal status, large tumors, and elevated Ki67 all associated with the choice for chemotherapy followed by endocrine therapy in hormone receptor-positive patients (𝑃<.0001). At univariate analysis, ER-ve status, chemotherapy and age resulted as the only statistically significant variables (HR=2.02, 𝑃=.004, and >40 versus ≤40, 𝑃<.0001, resp.). At multivariate analysis, after adjustment for significant clinical and pathological factors, age remains a significant prognostic variable (HR=0.93, 𝑃=.0021). Conclusion. This cohort study suggests that age per sè is an important prognostic factor. The restricted role of early diagnosis and the aggressive behavior of cancer in this population make necessary the application of targeted medical strategies crucial.http://dx.doi.org/10.4061/2011/534256
spellingShingle P. Pronzato
G. Mustacchi
A. De Matteis
F. Di Costanzo
E. Rulli
I. Floriani
M. E. Cazzaniga
Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study
International Journal of Breast Cancer
title Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study
title_full Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study
title_fullStr Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study
title_full_unstemmed Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study
title_short Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study
title_sort biological characteristics and medical treatment of breast cancer in young women a featured population results from the nora study
url http://dx.doi.org/10.4061/2011/534256
work_keys_str_mv AT ppronzato biologicalcharacteristicsandmedicaltreatmentofbreastcancerinyoungwomenafeaturedpopulationresultsfromthenorastudy
AT gmustacchi biologicalcharacteristicsandmedicaltreatmentofbreastcancerinyoungwomenafeaturedpopulationresultsfromthenorastudy
AT adematteis biologicalcharacteristicsandmedicaltreatmentofbreastcancerinyoungwomenafeaturedpopulationresultsfromthenorastudy
AT fdicostanzo biologicalcharacteristicsandmedicaltreatmentofbreastcancerinyoungwomenafeaturedpopulationresultsfromthenorastudy
AT erulli biologicalcharacteristicsandmedicaltreatmentofbreastcancerinyoungwomenafeaturedpopulationresultsfromthenorastudy
AT ifloriani biologicalcharacteristicsandmedicaltreatmentofbreastcancerinyoungwomenafeaturedpopulationresultsfromthenorastudy
AT mecazzaniga biologicalcharacteristicsandmedicaltreatmentofbreastcancerinyoungwomenafeaturedpopulationresultsfromthenorastudy